Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Ocuphire Pharma, Inc. in the transaction, and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan represented Opus Genetics Inc. Wilson Sonsini Goodrich & Rosati...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP served as legal advisor to Eldridge in the transaction, while Willkie Farr & Gallagher LLP, Fenwick & West LLP and Latham & Watkins...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Anthelion Capital Holdings (formerly known as Cowen Sustainable Investments) in the transaction. Anthelion Capital Holdings (formerly known as Cowen Sustainable Investments), announced the acquisition...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Guggenheim Securities, LLC and BTIG, LLC as underwriters on the deal. Guggenheim Securities, LLC and BTIG, LLC acted as underwriters in the US$230 million...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP and DLA Piper LLP advised Roche on the deal. Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics (NASDAQ: GNMK) announced that they have...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP, Conyers and Walkers Bermuda acted for Athene Holding on the deal. Athene Holding announced its proposed merger with Apollo Global Management, in an all-stock...
You must be a Standard 1 Year member to access this content.
